Probing Harvard for innovative HIV drug resistance approach - Joep Lange Institute

Probing Harvard for innovative HIV drug resistance approach

Tobias Rinke de Wit visited the Harvard School of Public Health in Boston, on behalf of the Joep Lange Institute, to elaborate on future on how to determine the HIV drug resistance of a population.

November 2017, Tobias Rinke de Wit visited the Harvard School of Public Health in Boston, on behalf of the Joep Lange Institute (JLI). This was possible with the help of Prof Jaap Goudsmit, Chair of the JLI Scientific Advisory Board. Tobias visited the school to elaborate on future on how to determine the HIV drug resistance of a population. He spent his time there brainstorming about innovative ideas how to research this topic with other professors at Harvard in the labs, besides giving a lecture about JLI and drug resistance research over the past ten years, in Africa specifically.

The desired and discussed way of determining drug resistance would include collecting representative samples on dried blood spots, mixing them, extracting the genetic material and determining the percentages of HIV drug resistance mutations on such a population as a whole. Not only would this method be very different from the current technologies, it would also prove to be a lot cheaper.

Discussion

Comments are closed.